找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Hepatocellular Carcinoma; Cellular and Molecul Rajagopal N. Aravalli,Clifford J. Steer Book 2014 The Author(s) 2014 Hepatocellular carcinom

[復(fù)制鏈接]
11#
發(fā)表于 2025-3-23 10:28:24 | 只看該作者
12#
發(fā)表于 2025-3-23 14:21:04 | 只看該作者
13#
發(fā)表于 2025-3-23 18:40:07 | 只看該作者
14#
發(fā)表于 2025-3-24 00:04:30 | 只看該作者
Rajagopal N. Aravalli,Clifford J. Steerontribute to the development and progression of prostate can.Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action
15#
發(fā)表于 2025-3-24 04:17:44 | 只看該作者
Rajagopal N. Aravalli,Clifford J. Steerontribute to the development and progression of prostate can.Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action
16#
發(fā)表于 2025-3-24 08:12:44 | 只看該作者
Rajagopal N. Aravalli,Clifford J. Steerontribute to the development and progression of prostate can.Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action
17#
發(fā)表于 2025-3-24 12:41:21 | 只看該作者
18#
發(fā)表于 2025-3-24 16:53:02 | 只看該作者
ion is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the androgen receptor (AR), a nuclear receptor transcription factor. ...Historically, the gene expression program mediated by the AR has been poorly understood. However,
19#
發(fā)表于 2025-3-24 22:40:28 | 只看該作者
Hepatocellular Carcinoma978-3-319-09414-4Series ISSN 2194-1173 Series E-ISSN 2194-1181
20#
發(fā)表于 2025-3-25 01:07:21 | 只看該作者
Rajagopal N. Aravalli,Clifford J. SteerIncludes supplementary material:
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 10:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
眉山市| 从江县| 疏附县| 临猗县| 巫溪县| 颍上县| 张家川| 宁陵县| 山阴县| 襄樊市| 延川县| 关岭| 张家口市| 浪卡子县| 洮南市| 新田县| 伽师县| 武城县| 雷山县| 仁怀市| 获嘉县| 大悟县| 丰城市| 古田县| 嵊泗县| 平潭县| 客服| 湟中县| 北京市| 廉江市| 商河县| 肇州县| 高雄市| 镇巴县| 涟水县| 温宿县| 内黄县| 绥江县| 准格尔旗| 正安县| 永登县|